Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients. (Q37506465)
Jump to navigation
Jump to search
scientific article published on 15 October 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients. |
scientific article published on 15 October 2011 |
Statements
Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients (English)
Karen Kato
Kozo Tanno
Kazuyoshi Itai
Yosuke Fujishima
Akira Okayama
Toshiyuki Onoda
Kazuyuki Suzuki
Motoyuki Nakamura
Kazuko Kawamura
Takashi Akiba
Kiyomi Sakata
Tomoaki Fujioka
15 October 2011